Level39, One Canada Square, Canary Wharf, London, E14 5AB
12th March 2025
8:30am – 5pm

Join us on the 12th March 2025 for the annual MediWales BioWales in London event in partnership with Canary Wharf Group, Abel + Imray, Welsh Government and Development Bank of Wales.

The Welsh life science sector is a thriving and dynamic ecosystem, particularly in the last few years, there have been significant developments around clinical innovation, medtech and diagnostics.

This event provides a unique platform for exciting new innovations and companies looking for investment and collaborations. With presentations from a variety of Welsh companies at various stages of their investor journey and an expert investor panel. We will also highlight NHS innovation and research collaboration opportunities, discussing clinical access, adoption and clinical trials.

Exclusive BioWales in London Accommodation Offer

Vertus Edit Canary Wharf have kindly offered discounted accommodation for delegates attending BioWales in London. Click here to claim your discount.

Draft programme :

More speakers to be announced soon

8.30am Registration

9am Welcome Presentations
Canary Wharf Group – Mairi Dillon, Associate Director – Science Ecosystem
MediWales – Gwyn Tudor, CEO
IQ Endoscopes – Matt Ginn, CEO
Llusern Scientific – Emma Hayhurst, CEO

10am VIP Panel
Setting the scene for collaboration across regions and nations from a government and healthcare perspective.

Welsh Government – Mike Emery, Chief Digital and Innovation Officer
AstraZeneca – Ed Piper, VP, Medical and Scientific Affairs Director
NHS Wales Executive – Dr Meinir Jones, National Clinical Director for Networks
Office for Life Sciences – Rosalind Campion, Director
UK Health Security Agency – Isabel Oliver, Chief Scientific Officer

NHS Health and and Research Stream

11:30am – 1pm Innovation and Adoption
Chaired by MediWales – Gwyn Tudor, CEO
ARCH – Sion Charles, Head of Strategy and Service Planning
Digital Health and Care Wales – Rachael Powell, Associate Director of Information, Intelligence and Research and Saddaf Shaheen, Head of Research and Innovation
NHS Wales Joint Commissioning Committee – Dr Rachel Gemine, Assistant Director of Evidence, Evaluation and Effectiveness
King’s College – London Institute of Health Engineering – Nicolas Huber, Director of Commercial Operations and Partnerships
Science and Engineering Health Technologies Alliance – Neil Roberts, Managing Director

Discussion and Q&A

2:15pm – 4:30pm Research and Collaboration
Chaired by ARCH – Sion Charles, Head of Strategy and Service Planning
Betsi Cadwaladr University Health Board and Medwise – Lynne Grundy, Associate Director Research and Development and Zar Salih, Partnerships Manager
Centre for Healthcare Evaluation, Device Assessment and Research – Kathleen Withers, Deputy Director
Health and Care Research Wales – Delyth Morgan, Head of Life Sciences Research and Industry Partnerships
Life Sciences Hub Wales – Dr James Bourne, Partnership Delivery Manager
Barts Life Sciences – Sarah Fothergill, HealthTech Lead
Tritech Institute – Gareth Davies, Clinical Scientist

Afternoon Plenary
UK Government – Secretary of State for Wales, The Rt Hon Jo Stevens MP

Industry Stream

11:30am – 1pm Technology Showcase and Future Watch
Chaired by Canary Wharf Group – Mairi Dillon, Associate Director – Science Ecosystem
CanSense – Dean Harris, Chief Medical Officer
Awen Oncology – Ramsay McFarlane, CEO
Valley Diagnostics – David Taylor, CEO
MeOmics – Lucy Sykes, CEO
Grove Nanomaterials – Richard Palmer, Founder
Biophys – James Preece, Chief Operations Officer

2:15pm – 3:30pm Company Showcase
Chaired by Immunoserv – James Hindley, CEO
Jellagen – Andrew Mearns Spragg, Chief Scientific Officer
Imspex Diagnostics – John McKinley, CEO
Simbec-Orion – Mark Bee, Vice President of Global Business Development
Onya Therapeutics – Emma Brodrick, Programme Management Lead
éclateral – Paul Ko Ferrigno, CEO
Tidewave – Andrew Smith, Director
YOURmeds – Nitin Parekh, Director and Co-Founder

3:30pm – 4:30pm Investor Panel supported by the Development Bank of Wales

Q&A with the UK’s most active life science investors.

Chaired by Abel + Imray – Lindsey Kent, Of Counsel

Development Bank of Wales – Duncan Gray, Technology Venture Investments Director
Maven Capital Partners – Alexandra Lindsay, Investments Director
THENA Capital – Saran Davies, Venture Partner
Business Growth Fund – Tim Rea, Co-Head of Early Stage

Drinks Reception 5-7pm
Kindly supported by Welsh Government London Office

We have limited sponsorship and exhibition opportunities available.
If you would like to find out more or get involved in the programme, please contact us here.

BioWales in London is free to all MediWales members. You can register here.

Non members are welcome to attend BioWales in London at a rate of £125 + VAT. If you would like attend as a non-member, please contact us.

Media Partners for the 2025 BioWales in London conference